Highlights : BPC 157 Counteracts Neural Damage : This peptide has shown remarkable results in reducing neuronal damage and promoting recovery post-stroke
The present study, for the first time, demonstrates an underlying mechanism for the activation of eNOS by BPC 157 on stimulating the Cav-1 phosphorylation and reducing the binding of eNOS to Cav-1
Cross-viral species recognition by coronavirus-reactive T cells has been well described, with SARS-CoV-2-reactive T cells being reported in samples taken before SARS-CoV-2 circulated in humans
Starting BPC-157 therapy often brings fast, visible changes
BPC-157 Dosage Chart U-100 insulin syringe units for the most common BPC-157 doses, calculated at the standard 5 mg / 2.5 mL reconstitution (2 mg/mL)
Patricia Brubaker, Ph.D., F.R.S.C., F.C.A.H.S